DNA methylation and leukemia susceptibility in China: Evidence from an updated meta‑analysis
- Authors:
- Danjie Jiang
- Yirun Li
- Qingxiao Hong
- Yusheng Shen
- Chunjing Xu
- Yan Xu
- Huangkai Zhu
- Dongjun Dai
- Guifang Ouyang
- Shiwei Duan
-
Affiliations: Medical Genetics Center, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, P.R. China, Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China - Published online on: July 12, 2016 https://doi.org/10.3892/mco.2016.959
- Pages: 193-207
This article is mentioned in:
Abstract
Davis AS, Viera AJ and Mead MD: Leukemia: An overview for primary care. Am Fam Physician. 89:731–738. 2014.PubMed/NCBI | |
Zhong S, Chen Z, Yu X, Chen W, Lv M, Ma T and Zhao J: Tea consumption and leukemia risk: A meta-analysis. Tumour Biol. 35:5205–5212. 2014. View Article : Google Scholar : PubMed/NCBI | |
Greim H, Kaden DA, Larson RA, et al: The bone marrow niche, stem cells, and leukemia: Impact of drugs, chemicals, and the environment. Ann NY Acad Sci. 1310:7–31. 2014. View Article : Google Scholar : PubMed/NCBI | |
Laurier D, Grosche B, Auvinen A, et al: Childhood leukaemia risks: From unexplained findings near nuclear installations to recommendations for future research. J Radiol Prot. 34:R53–R68. 2014. View Article : Google Scholar : PubMed/NCBI | |
Malinge S, Chlon T, Doré LC, et al: Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes. Blood. 122:e33–e43. 2013. View Article : Google Scholar : PubMed/NCBI | |
Wakeford R: The risk of childhood leukaemia following exposure to ionising radiation - a review. J Radiol Prot. 33:1–25. 2013. View Article : Google Scholar : PubMed/NCBI | |
Woo JS, Alberti MO and Tirado CA: Childhood B-acute lymphoblastic leukemia: A genetic update. Exp Hematol Oncol. 3:162014. View Article : Google Scholar : PubMed/NCBI | |
Bhatia S: Disparities in cancer outcomes: Lessons learned from children with cancer. Pediatr Blood Cancer. 56:994–1002. 2011. View Article : Google Scholar : PubMed/NCBI | |
Carranza C, Granados L, Morales O, et al: Frequency of the ETV6-RUNX1, BCR-ABL1, TCF3-PBX1, and MLL-AFF1 fusion genes in Guatemalan pediatric acute lymphoblastic leukemia patients and their ethnic associations. Cancer Genet. 206:227–232. 2013. View Article : Google Scholar : PubMed/NCBI | |
Goggins WB and Lo FF: Racial and ethnic disparities in survival of US children with acute lymphoblastic leukemia: Evidence from the SEER database 1988–2008. Cancer Causes Control. 23:737–743. 2012. View Article : Google Scholar : PubMed/NCBI | |
Kennedy AE, Kamdar KY, Lupo PJ, et al: Genetic markers in a multi ethnic sample for childhood acute lymphoblastic leukemia risk. Leuk Lymphoma. 56:169–174. 2014. View Article : Google Scholar : PubMed/NCBI | |
Savage SA: Genomic clues to ethnic differences in ALL. Blood. 123:2440–2442. 2014. View Article : Google Scholar : PubMed/NCBI | |
Lim JY, Bhatia S, Robison LL and Yang JJ: Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia. Cancer. 120:955–962. 2014. View Article : Google Scholar : PubMed/NCBI | |
Adkins RM, Krushkal J, Tylavsky FA and Thomas F: Racial differences in gene-specific DNA methylation levels are present at birth. Birth Defects Res A Clin Mol Teratol. 91:728–736. 2011. View Article : Google Scholar : PubMed/NCBI | |
Xia YY, Ding YB, Liu XQ, et al: Racial/ethnic disparities in human DNA methylation. Biochim Biophys Acta. 1846:258–262. 2014.PubMed/NCBI | |
Baylin SB and Jones PA: A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 11:726–734. 2011. View Article : Google Scholar : PubMed/NCBI | |
Plass C, Pfister SM, Lindroth AM, et al: Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nat Rev Genet. 14:765–780. 2013. View Article : Google Scholar : PubMed/NCBI | |
Jiang D, Hong Q, Shen Y, et al: The diagnostic value of DNA methylation in leukemia: A systematic review and meta-analysis. PLoS One. 9:e968222014. View Article : Google Scholar : PubMed/NCBI | |
Higgins JP, Thompson SG, Deeks JJ and Altman DG: Measuring inconsistency in meta-analyses. BMJ. 327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI | |
Bax L, Ikeda N, Fukui N, Yaju Y, Tsuruta H and Moons KG: More than numbers: The power of graphs in meta-analysis. Am J Epidemiol. 169:249–255. 2009. View Article : Google Scholar : PubMed/NCBI | |
Pluta A, Nyman U, Joseph B, Robak T, Zhivotovsky B and Smolewski P: The role of p73 in hematological malignancies. Leukemia. 20:757–766. 2006. View Article : Google Scholar : PubMed/NCBI | |
Cahill N and Rosenquist R: Uncovering the DNA methylome in chronic lymphocytic leukemia. Epigenetics. 8:138–148. 2013. View Article : Google Scholar : PubMed/NCBI | |
Esteller M: CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future. Oncogene. 21:5427–5440. 2002. View Article : Google Scholar : PubMed/NCBI | |
Zhao Y, Guo J, Zhang X, et al: Downregulation of p21 in myelodysplastic syndrome is associated with p73 promoter hypermethylation and indicates poor prognosis. Am J Clin Pathol. 140:819–827. 2013. View Article : Google Scholar : PubMed/NCBI | |
Volodko N, Gordon M, Salla M, Ghazaleh HA and Baksh S: RASSF tumor suppressor gene family: Biological functions and regulation. FEBS Lett. 588:2671–2684. 2014. View Article : Google Scholar : PubMed/NCBI | |
Benezra R, Davis RL, Lockshon D, Turner DL and Weintraub H: The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell. 61:49–59. 1990. View Article : Google Scholar : PubMed/NCBI | |
Bodoor K, Haddad Y, Alkhateeb A, et al: DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients. Asian Pac J Cancer Prev. 15:75–84. 2014. View Article : Google Scholar : PubMed/NCBI | |
Chmelařová M, Křepinská E, Spaček J, Laco J, Nekvindová J and Palička V: Methylation analysis of tumour suppressor genes in ovarian cancer using MS-MLPA. Folia Biol (Praha). 58:246–250. 2012.PubMed/NCBI | |
Cechova H, Lassuthova P, Novakova L, et al: Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia. Neoplasma. 59:168–174. 2012. View Article : Google Scholar : PubMed/NCBI | |
Deligezer U, Erten N, Akisik EE and Dalay N: Methylation of the INK4A/ARF locus in blood mononuclear cells. Ann Hematol. 85:102–107. 2006. View Article : Google Scholar : PubMed/NCBI | |
Hsiao PC, Liu MC, Chen LM, et al: Promoter methylation of p16 and EDNRB gene in leukemia patients in Taiwan. Chin J Physiol. 51:27–31. 2008.PubMed/NCBI | |
Zheng R, Shen S, Shen J and Ma X: Studies on p16, p15, p18 and p19 methylation of INK4 series cancer inhibitive gene in leukemia. J Fujian Med Univ. 38:257–260. 2004. | |
Xiao Y, Liu Y, Jiang L and Ran L: Study on the deletion point mutation and promoter methylation analysis of p16 in leukemia. Guizhou Med J. 34:784–787. 2010. | |
Yang J, Li X, Sun L, Song G, Chen H and Liu Y: Expression of p16 gene in adult acute leukemia. J Zhengzhou Univ (Med Sci Ed.). 38:33–36. 2003. | |
Song G, Yang J, Sun H, Liu C, Chen H and Li X: Deletion and methylation of p16 gene in an adult acute leukemia. Henan J Oncol. 17:229–231. 2004. | |
Tan G and Guo X: Methods of CpG islands methylation detection. J Jinan Univ. 22:24–26. 2001. | |
Zhu C, Xu W, Liu D, Wang Y and Bi K: Study of the methylation of p15 and p16 gene in acute leukemia. Shandong Med J. 45:4–5. 2005. | |
Zhang J, Wu J and Tan Y: The relationship between P16 gene inactivation and expression of mRNA in ALL. J Wenzhou Med Coll. 30:5–7. 2000. | |
Fan L, Shen J, Ye B, et al: Detection of p16 gene methylation status in adult patients with acute leukemia by using n-MSP. J Exp Hematol. 15:258–261. 2007. | |
Jiang J, Shen J, Yan J, et al: The value of p15 gene methylation in minimal residual disease of childhood acute leukemia by MSP. China Child Blood. 7:1–3. 2002. | |
Meng Y, Yu H, Guo C, et al: Quantitative analysis of p15 and p16 gene methylation and mRNA expression levels in acute leukemia patients. Chin J Hematol. 26:434–435. 2005. | |
Wang B: The clinical significance of p16 gene methylation in leukemia and other hematologic malignancies. Master's degree dissertation, China Medical University. 2002. | |
Yin Y: The clinical significance of p15 gene methylation in leukemia and other hematologic malignancies. Master's degree dissertation, China Medical University. 2002. | |
Chen H, Sun H, Liu C, Liu Y, Song G and Li X: Methylation of p16/p15 exon 2 in adult acute myeloid leukemia. J Zhengzhou Univ (Med Sci Ed.). 38:722–724. 2003. | |
Lin F, Ye B, Shen J, et al: Detection of p15 methylation and deletion status in acute lymphoblastic leukemia using hn-MSP. J Leuk Lymphoma. 21:208–212. 2012. | |
Zhu C, Bi K and Liu X: Homozygous deletion and methylation of P15 gene in acute laukemia. Shandong Med J Shandong Yiyao. 41:10–11. 2001. | |
Shen Z, Zhang J, Yu K and Jiang S: Evaluation of methylation-specific polymerase chain reaction and its potential clinical value in detecting minimal residual disease of adult acute leukemia with P15. J Wenzhou Med Coll. 32:230–232. 2002. | |
Fan H, Guo X, Tan G, Wu Q, Zhou T and Guo Q: Study on methylation of p15 INK4B in myelodysplastic syndrome. Chin J Pathophysiol. 17:349–352. 2001. | |
Tong H and Lin M: Methylation of p15INK4B gene and its mechanism in patients with myelodysplastic syndrome and leukemia. Chin J Pathophysiol. 20:2257–2260. 2004. | |
Guo X, Fan H, Wu Q, et al: Study on methylation of p15INK4B gene in acute myeloid leukemia and chronic myeloid leukemia. J Exp Hematol. 8:257–260. 2000. | |
Qiao S, Xu S, Guo X and Wang Y: Clinical significance of the expression of DNA methyltransferase genes (DNMT) in acute leukemia patients. J Exp Hematol. 13:260–265. 2005. | |
Chen F and Zeng X: Detection of p15 gene hypermethylation in acute leukemia by MSP. Chin J Hematol. 21:2502000. | |
Yin Y, Li Y and Liu D: The clinical significance of p15 gene methylation in leukemia and other hematologic malignancies. Chin J Hematol. 24:383–384. 2003. | |
Wu D: p15INK4b gene DNA methylation and histone modification mechanism of leukemia cell mediated by p15-piRNAs. PhD dissertation, Fujian Medical University. 2013. | |
Wang H: The study of p15 gene methylation in malignancies. Master's degree dissertation, Qingdao University. 2002. | |
Zhao Y, Wang QS, Li HH, et al: [Significance of id4 promoter methylation in monitoring AML patients with completely remission]. J Exp Hematol. 16:476–478. 2008. | |
Wang X, Kang H, Cen J, Li Y, Wang L and Yu L: Methylation Status of id4 gene promoter in patients with chronic myeloid leukemia. J Exp Hematol. 18:1402–1404. 2010. | |
Liu F, Xu R, Cui X, Zhang X and Wang Y: ID4 promoter methylation in acute myeloid leukemia. J Exp Hematol. 19:582–584. 2011. | |
Jie X: WT1, ID4, GLIPR1 aberrant gene promoter methylation and mRNA expression in leukemia patients. Master's degree dissertation, Guangdong Medical College. 2012. | |
Zhao Y: The significance of Id4 gene methylation in hematological malignancies. PhD dissertation, PLA Postgraduate Medical School. 2005. | |
Xiao YH, Li XH, Tan T, et al: Identification of GLIPR1 tumor suppressor as methylation-silenced gene in acute myeloid leukemia by microarray analysis. J Cancer Res Clin Oncol. 137:1831–1840. 2011. View Article : Google Scholar : PubMed/NCBI | |
Liang T, Tan T, Xiao Y, et al: Methylation and expression of glioma pathogenesis-related protein 1 gene in acute myeloid leukemia. J Cent South Univ (Med Sci Ed.). 34:388–394. 2009. | |
Zhang Y, Gao Y, Wang X, et al: The relationship between p73 gene methylation and childhood acute leukemia. Proceedings of the Ninth National Conference on Environmental and Occupational Medicine Graduate (Shanghai, China). 254–256. 2010. | |
Zhang H, Mo W and Yang Z: The expression of WWOX and p73 in acute myeloid leukemia. Guangdong Med J. 33:1567–1570. 2012. | |
Wu C, Jin J, Ji Y, et al: Abnormal expression and significance of p73 gene in adult acute lymphoblastic leukemia. Jiangsu Med J. 34:339–341. 2008. | |
Liu J, Jiang Y, Xu W and Liang X: Alterations of p53 and p73 genes in lympho-plasmacytic diseases. Pract Clin Med. 6:9–13. 2005. | |
Xu W: Study on methylation of the p73 gene in acute lymphoblastic leukemia and its clinical significances. Chin J Pract Int Med. 25:905–906. 2005. | |
Yu G: Abnormal expression of p73 gene in adult acute lymphoblastic leukemia. Med Innov Chin. 2:121–122. 2014. | |
Xie X, Chen Z, Zhang X and Huang M: Detecting methylation of the calcitonin gene in monitoring treatment and disease evolution for myelogenous leukemia. Chin J Cancer. 22:616–619. 2003. | |
Tang Y, Deng C, Du Q and Li G: Study on hypermethylation of the calcitonin gene in malignant hematological disorders. J West Chin Univ Med Sci. 32:86–88. 2001. | |
Wang S, Hong W and Peng A: The study of CT gene methylation in chronic myeloid leukemia. Chin J Hematol. 19:321998. | |
Qian J, Yao D, Lin J, et al: Alteration of methylation status of death-associated protein kinase (dapk) gene promoter in patients with acute myeloid leukemia. J Exp Hematol. 18:1390–1394. 2010. | |
Niu Y, Wang P, Wang Y, Wang Y, Cai D and Li Y: Expression of death-associated protein kinase gene and methylation status of promoter region in acute leukimia. J Exp Hematol. 22:30–34. 2014. | |
Zhao W: DAPK gene promoter methylation, expression and biological function in acute leukemia. PhD dissertation, Southern Medical University. 2009. | |
Qian J, Wang YL, Lin J, Yao DM, Xu WR and Wu CY: Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia. Eur J Haematol. 82:119–123. 2009. View Article : Google Scholar : PubMed/NCBI | |
Lin W, Ye Z and Tan J: Gene methylation abnormalities in chronic lymphocytic leukemia patients by PCR. J Qiqihar Med Coll. 31:2376–2377. 2010. | |
Wu B, Chen E and Zhu B: Detecting the aberrant methylation of progesterone receptor B gene in human chronic lymphocytic leukemia by MSP. Chin J Hemorheol. 18:140–141. 2008. | |
Zhang X: The experimental study of PR promoter CpG island methylation in leukemia. Master's degree dissertation, Third Military Medical University. 2003. | |
Shi X, Chang N, Fan Y, et al: Detection and clinical significance of SFRP2 promoter methylation status in patients with acute myeloid leukemia. Chin J Clin, Electron Ed. 5:1962–1966. 2011. | |
Wang H, Zhang G, Yao K, et al: The gene methylation and protein expression of SFRP5 in leukemic cells. J China Med Univ. 41:2012. | |
Xu C, Shen J, Shen S, Fu H, Zhu Y and Chen L: The significance of methylation status of secreted frizzled-related protein gene promoter in acute leukemia. Chin J Intern Med. 49:769–771. 2010. | |
Li M: A preliminary study of inactivation of IGSF4 gene methylation in leukemia cell. PhD dissertation, PLA Postgraduate Medical School. 2004. | |
Chen W, Huang C, Zhan X, et al: RASSF1A gene methylation and its clinical significance in leukemia patients. Lab Med. 27:554–556. 2012. | |
Song J, Li Y, Yang Z, Yang L and Chen J: Hypermethylation in SFRP2 promoter in human leukemia K562 cells and bone marrow specimen with chronic myeloid leukemia. Acad J Third Med Coll PLA. 33:2583–2586. 2011. | |
Dou L: The study of LRP15 gene methylation in blood diseases. Master's degree dissertation, PLA Postgraduate Medical School. 2004. | |
Yao C, Fang J, Gao L, Ding J, Shu G and Yu W: Study on the relationship between the RIZ1 gene expression and methylation status of the gene promoter in acute myeloid leukemia. J Southeast Univ (Med Sci Ed.). 29:119–122. 2010. | |
Cai F: RIZ1 gene expression and promoter methylation status in acute childhood leukemia. PhD dissertation, Huazhong University Science and Technology. 2012. | |
Shi X, Fan Y, Zhou C, et al: Study of abnormal methylation in the promoter region of SFRP4 gene in acute myeloid leukemia. Chin J Clin, Electron Ed. 5:990–995. 2011. | |
Dou LP, Liu JH, Wang C, et al: [Study on the involvement of ZO-1 gene in leukemogenesis]. Chin J Hematol. 30:473–476. 2009. | |
Wang C, Wang G, Tan Y, Li W, Liu C and Yu L: The methylation pattern and clinical significance of Zonula occludens-1 gene promoter in acute leukemia. Chin J Intern Med. 47:111–113. 2008. | |
Chim CS, Wong SY, Pang A, et al: Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia. Leukemia. 19:2241–2246. 2005. View Article : Google Scholar : PubMed/NCBI | |
Wang G, Liu L, Chen J, et al: Promoter methylation profile of androgen receptor gene in leukemic cells. J Third Mil Med Univ. 29:932–934. 2007. | |
Wang X, Li J, Fu B, Guo L, Zhang J and Huang S: Methylation Status of JunB and CDH13 gene promoter in CD34 CD38−chronic myelogenous leukemia cells. J Exp Hematol. 17:1405–1408. 2009. | |
Liu J: CDH13 gene promoter methylation and expression in acute myeloid leukemia. Master's degree dissertation, Guangzhou Medical University. 2013. | |
Wang Y: The study of DDIT3 gene promoter methylation in hematological tumors. Master's degree dissertation, Jiangsu University. 2009. | |
Zhu X, Zhu C, Wan Y, et al: Analysis of methylation of the Dickkopf1 (DKK-1) gene in acute leukemia. J Shandong Univ (Health Sci). 50:84–87. 2012. | |
Yuan X: The study of EDNRB gene promoter methylation in acute leukemia. Master's degree dissertation, Zhengzhou University. 2010. | |
Yu Y: The study of FANCF methylation in patients with acute myeloid leukemia and myelodysplastic syndrome. Master's degree dissertation, China Medical University. 2008. | |
Deng N: The study of FANCF/FANCD2 expression in patients with acute myeloid leukemia and myelodysplastic syndrome. Master's degree dissertation, China Medical University. 2009. | |
Qian Z: The significance of GRAF gene promoter methylation in hematopoietic tumors. Master's degree dissertation, Jiangsu University. 2010. | |
Chen Q: HAGE gene promoter hypomethylation in myeloid tumors. Master's degree dissertation, Jiangsu University. 2012. | |
Li Y, Wang Y, Zhou J, Zhou S, Fang G and Liu X: Analysis and clinical significance of hPer3 promoter methylation status for CML monitoring. Chin J Pathophysiol. 27:2111–2115. 2011. | |
Wang Y, Zhou J, Zhou S, et al: Promoter methylation status of hPer3 gene in AML patients and the in vitro effect of decitabine on the status. Chin J Hematol. 32:317–321. 2011. | |
Wang N: MiR-34b expression, methylation regulation and clinical significance in acute childhood leukemia. Master's degree dissertation, Suzhou University. 2013. | |
Chai H: RAGE-1 gene promoter hypomethylation in myeloid tumors. Master's degree dissertation, Shanxi Medical University. 2013. | |
Lin D, Fan R and Liu X: Significance of DNA methylation status of runx3 gene promoter region in acute leukemia. J Exp Hematol. 16:263–266. 2008. | |
Chim CS, Wong AS and Kwong YL: Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias. Ann Hematol. 83:527–532. 2004. View Article : Google Scholar : PubMed/NCBI | |
Wang Y, Zhu CS, Bi KH, Xu WW, Dong L and Hou M: [Study of WIF-1 promoter methylation with expressions of β-catenin in acute leukemia]. Chin Med J. 91:2858–2860. 2011. | |
Liu W, Xu C, Guan M and Zhang Y: Aberrant promoter hypermethylation of AKAP12 gene in acute lymphoblastic leukemia in children. Lab Med. 23:344–348. 2008. | |
Gao F, Li Y, Liu W, et al: Studies on gene expression and the 5′ CpG islands methylation status of E-cadherin in acute myeloid leukemia. Chin J Hematol. 27:25–27. 2006. | |
Yao DM, Qian J, Lin J, et al: Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia. Leuk Res. 35:957–960. 2011. View Article : Google Scholar : PubMed/NCBI | |
Guan M, Xu C, Liu W and Chen B: Identification of aberrant methylation of DLC-1 by pyrosequencing in acute lymphoblastic leukemia in children. Chin J Lab Med. 31:389–393. 2008. | |
Yu L, Wang Q, Gu Q, Shi Z and Jin H: Study on aberrant DNA methylation of dopamine D4 receptor gene in acute myeloid leukemia. Acad J Chin PLA Postgrad Med Sch. 21:62–64. 2000. | |
Tao YF, Xu LX, Lu J, et al: Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation. J Transl Med. 12:1822014. View Article : Google Scholar : PubMed/NCBI | |
Zheng Y: Abnormal methylation of the promoter region of the p53 gene in acute leukemia. Master's degree dissertation, Sun Yat-sen University. 2007. | |
Li Y, Qian J, Chen Q, et al: Expression pattern and promoter hypermethylation of PDLIM4 gene in patients with chronic myeloid leukemia. J Jiangsu Univ (Med Ed.). 23:17–21. 2013. | |
Song JJ, Liu Q, Li Y, et al: Epigenetic inactivation of PLCD1 in chronic myeloid leukemia. Int J Mol Med. 30:179–184. 2012.PubMed/NCBI | |
Yao D, Qian J, Lin J, Li Y, Chen Q and Chen X: Alteration of methylation status of PRAME gene promoter in patients with chronic myeloid leukemia. J Pract Med. 29:3495–3498. 2013. | |
Yan W, Hu W and Yang W: Expression and methylation study of PRDX2 gene in acute myeloid leukemia. J China Med Univ. 41:1047–1049. 2012. | |
Yang J, Du W, He Y, Liu J, Zheng J and Huang S: Research on PTEN expression and its promoter methylation in B-ALL patients. J Intern Intens Med. 13:141–143. 2007. | |
Du C, Mao P and Wang Y: The clinical significance of the RIL gene methylation levels in acute myeloid leukemia. China J Mod Med. 23:46–51. 2013. | |
Jiao X, Chen Q, Lin J, et al: SALL4 genes methylation changes and clinical significance in acute myeloid leukemia patients. J Jiangsu Univ (Med Ed.). 23:532–535. 2013. | |
Zhuang Y, Cheng Y, Wang L, Dou H, Zhu Q and Hu J: The methylation of SOCS-1 gene in adult acute myeloid leukemia. Prog Mod Biomed. 18:3417–3420. 2011. | |
Deng G, Li ZQ, Zhao C, et al: WNT5A expression is regulated by the status of its promoter methylation in leukaemia and can inhibit leukemic cell malignant proliferation. Oncol Rep. 25:367–376. 2011.PubMed/NCBI | |
Iacobucci I, Ferrari A, Lonetti A, et al: CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients. Clin Cancer Res. 17:7413–7423. 2011. View Article : Google Scholar : PubMed/NCBI | |
Hu HB and Hu Q: ID4 methylation patterns in childhood T line and B line lymphocytic leukemia. Chin J Contemp Pediatr. 12:940–942. 2010.(In Chinese). | |
Chen SS, Claus R, Lucas DM, et al: Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL. Blood. 117:862–871. 2011. View Article : Google Scholar : PubMed/NCBI | |
Liu Y, Kang HY, Wang LL, Lu XC, Zhu HL and Yu L: Establishment of methylation-specific quantitative PCR system for ID4 gene in acute leukemia cells and its specificity and sensitivity. J Exp Hematol. 22:269–274. 2014.(In Chinese). | |
Liu F and Xu RR: Study on the correlation between Chinese medical syndrome types and ID4 gene promoter methylation in human acute myeloid leukemia. Chin J Integr Tradit West Med. 32:471–473. 2012.(In Chinese). | |
Awasthi A, Woolley AG, Lecomte FJ, et al: Variable expression of GLIPR1 correlates with invasive potential in melanoma cells. Front Oncol. 3:2252013. View Article : Google Scholar : PubMed/NCBI | |
Capalbo G, Mueller-Kuller T, Koschmieder S, et al: Endoplasmic reticulum protein GliPR1 regulates G protein signaling and the cell cycle and is overexpressed in AML. Oncol Rep. 30:2254–2262. 2013.PubMed/NCBI | |
He Z, Liu H, Agostini M, et al: p73 regulates autophagy and hepatocellular lipid metabolism through a transcriptional activation of the ATG5 gene. Cell Death Differ. 20:1415–1424. 2013. View Article : Google Scholar : PubMed/NCBI | |
Toska E and Roberts SG: Mechanisms of transcriptional regulation by WT1 (Wilms tumour 1). Biochem J. 461:15–32. 2014. View Article : Google Scholar : PubMed/NCBI | |
Dores GM, Devesa SS, Curtis RE, Linet MS and Morton LM: Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood. 119:34–43. 2012. View Article : Google Scholar : PubMed/NCBI | |
Shirley MH, Sayeed S, Barnes I, Finlayson A and Ali R: Incidence of haematological malignancies by ethnic group in England, 2001-7. Br J Haematol. 163:465–477. 2013. View Article : Google Scholar : PubMed/NCBI |